Favilavir, formerly known as Fapilavir, an antiviral that has shown efficacy in treating the novel coronavirus, was approved for marketing, the Taizhou government in Zhejiang province announced Sunday.

BEIJING, Feb. 18 (Xinhua) -- China's daily new confirmed cases of the novel coronavirus pneumonia outside Hubei, the epicenter province of the outbreak, have dropped for 14 consecutive days, according to the National Health Commission Tuesday.

On the afternoon of 17 February, the State Council inter-agency task force on responding to the novel coronavirus pneumonia (NCP, or COVID-19) outbreak held a press briefing on the latest progress in medical treatment of NCP cases.

The international community has spoken highly of Chinese President Xi Jinping's emphasis on improving the mechanism for major epidemic prevention and control, saying such a move will further enhance the country's governance capacity, which is of great significance to China and the world.

In the battle against COVID-19, emerging technologies have stood out by making immense contributions in an unexpected, creative and amazingly responsive way. In the process, they have helped arrest or contain the spread of the deadly virus, thus becoming one of the most reliable and trustworthy means of combating COVID-19.

China's daily new confirmed cases of the novel coronavirus pneumonia outside Hubei, the epicenter province in the outbreak, have dropped for 13 consecutive days, according to the National Health Commission.

Here are some encouraging medical research developments achieved over the weekend related to the fight against the novel coronavirus.

At today's press briefing organized by the State Council inter-agency task force, Mi Feng, an NHC spokesperson and a Deputy Director-General for Communications, said that as of 24:00, 15 February, the share of severe cases in confirmed cases had registered a clear drop in Wuhan and Hubei as well as in other parts of the country.

Here are some encouraging medical research developments achieved over the weekend

hina's daily new confirmed cases of the novel coronavirus pneumonia outside Hubei

Transcript of State Councilor and Foreign Minister Wang Yi’s Exclusive Interview with Reuters

Since Jin Jiang International acquired a majority stake in Radisson Hotel Group last year, the latter’s loyalty program, Radisson Rewards, has been collaborating with the former’s booking platform WeHotel and loyalty program WeHotel Prime.

Among the Top 25 Markets, Minneapolis/St. Paul, Minnesota, registered the largest increase in RevPAR (+13.5% to US$123.21), due primarily to the largest lift in ADR (+8.2% to US$141.35). The market saw the second-highest rise in occupancy (+4.9% to 87.2%).

OYO Hotels & Homes, a lodging operator backed by SoftBank’s Vision Fund, is betting the same formula that fueled the company’s rapid growth in India and China can work in the U.S.

Spain-based global bedbank Hotelbeds has launched the Chinese version of hotel extranet Maxiroom.

A Series A round of €3 million will be heading the way of MagicStay following financial backing from a group of individual investors.

Hyatt Hotels Corp. and BTG Homeinns Hotels Group revealed the name of their upcoming upper-midscale brand.

Baidu, one of the biggest internet giants in the world and China’s top search engine, recently released its hotel ads product across multiple platforms.

Types of ownership can be crucial determining factors in hotel firm performance.

Hotel chain OYO has partnered with Meituan Hotels, the hospitality service housed under the eponymous Meituan platform, reports Sina Tech.